Nautilus Biotechnology (NAUT) Interest & Investment Income (2021 - 2026)

Nautilus Biotechnology has disclosed Interest & Investment Income across 6 years of filings, most recently posting $1.4 million for Q1 2026.

• Interest & Investment Income for Q1 2026 came in at $1.4 million, down 35.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.1 million (down 30.15% YoY), and the FY2025 annual result was $7.9 million, down 27.01% from the prior year.
• Interest & Investment Income came in at $1.4 million for Q1 2026 at Nautilus Biotechnology, down from $1.7 million in the prior quarter.
• In the past five years, Interest & Investment Income ranged from a high of $3.2 million in Q2 2023 to a low of $264000.0 in Q1 2022.
• The 5-year median for Interest & Investment Income is $2.4 million (2024), against an average of $2.3 million.
• Across the five-year window, Interest & Investment Income jumped 1693.17% in 2022 and slumped 35.37% in 2026, its largest moves.
• Nautilus Biotechnology's Interest & Investment Income stood at $2.9 million in 2022, then gained by 5.06% to $3.0 million in 2023, then dropped by 19.85% to $2.4 million in 2024, then plunged by 31.96% to $1.7 million in 2025, then declined by 12.82% to $1.4 million in 2026.
• The last three Interest & Investment Income figures came in at $1.4 million (Q1 2026), $1.7 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.